日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: PAX8-AS1 knockdown facilitates cell growth and inactivates autophagy in osteoblasts via the miR-1252-5p/GNB1 axis in osteoporosis

撤稿声明:PAX8-AS1敲低通过miR-1252-5p/GNB1轴促进骨质疏松症中成骨细胞的生长并抑制自噬。

Huang, Caiqiang; Li, Runguang; Yang, Changsheng; Ding, Rui; Li, Qingchu; Xie, Denghui; Zhang, Rongkai; Qiu, Yiyan

PAX8-positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles - A clinicopathologic study of 101 consecutive cases with next-generation sequencing in 20 cases

PAX8阳性膀胱常规尿路上皮癌及其独特的分子特征——一项对101例连续病例进行临床病理学研究,其中20例进行了二代测序

Lammert, Sarah Mae; Luo, Wendy; Zhu, Allen C; Wang, Peng; Antic, Tatjana; Kwon, Jung Woo

A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma

采用 CK17、MEP1A、PAX8、SMAD4 和 CDX2 这 5 种标记物的免疫组化检测方法,可鉴别卵巢黏液性癌和转移性胰腺导管腺癌。

De Boeck, Astrid; Kang, Eun Young; Meagher, Nicola S; Gorringe, Kylie L; Lee, Cheng Han; Minoo, Parham; Köbel, Martin

A Combined Transcriptomic and Machine Learning Study Reveals PAX8 as a Promising Diagnostic Biomarker in Endometriosis

一项结合转录组学和机器学习的研究表明,PAX8 是一种有前景的子宫内膜异位症诊断生物标志物

Zhu, Xiaoli; Zhong, Li; Xu, Yanlin; Zou, Yuanxia; Liu, Manyun; Tong, Xiaoqian

Case Report: Membranous/cytoplasmic Ki-67 staining and PAX8-GLIS3 fusion: defining the clinicopathological spectrum of hyalinizing trabecular tumor to optimize patient management

病例报告:膜/胞质 Ki-67 染色和 PAX8-GLIS3 融合:明确透明变性小梁状肿瘤的临床病理谱以优化患者管理

Huang, Haining; Zhao, Ran; Zhang, Liman; Ren, Shujun; Liu, Jianli; Yang, Dandan; Zhang, Junjun; Zhang, Renya; Chen, Shuai; Li, Lei

SOX17/PAX8 dual immunohistochemical expression in the diagnosis of Müllerian carcinomas

SOX17/PAX8双重免疫组化表达在苗勒氏管癌诊断中的应用

Moustafa, Manar; Abdalrahman, Marwa Ahmed Mohamed; Abdelgeleel, Heba Mahmoud

TET1 loss propels the development of hyperthyroidism by remodeling histone modifications of PAX8 promoter

TET1 缺失通过重塑 PAX8 启动子的组蛋白修饰促进甲状腺功能亢进症的发展。

Dang, Hui; Liu, Yan; Zhou, Ye; Sui, Mengjun; Wang, Yubo; Qiang, Wei; Sui, Fang; Zhang, Yan; Cao, Hongxin; Wu, Xiaoyan; Ji, Meiju; Hou, Peng

Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancer

PAX8转录因子结合位点的罕见种系遗传变异与上皮性卵巢癌的易感性相关

Ezquina, Suzana A M; Jones, Michelle; Dicks, Ed; de Vries, Amber; Peng, Pei-Chen; Lawrenson, Kate; Corona, Rosario I; Tyrer, Jonathan; Hazelett, Dennis; Brenton, James; Antoniou, Antonis; Gayther, Simon A; Pharoah, Paul D P

Corrigendum to "High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer" [Translational oncology vol. 50 (2024): 102128]

对“PAX8-AS1 高表达与 II 期结肠癌预后不良及对氟尿嘧啶类化疗的反应相关”的更正 [转化肿瘤学卷 50 (2024): 102128]

Fang, Hongsheng; Han, Lingyu; Xu, Yun; Gu, Ruiqi; Cai, Guoxiang; Xia, Zuguang; Dai, Weixing; Wang, Renjie

Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry

通过SOX17和PAX8免疫组化联合检测来鉴定子宫内膜中肾样腺癌

Tahir, Maryam; Xing, Deyin; Ding, Qingqing; Wang, Yihong; Singh, Kamaljeet; Suarez, Adrian A; Parwani, Anil; Li, Zaibo